Filing Details
MoonLake Immunotherapeutics (NASDAQ:MLTX) filed a Form 8-K with the Securities and Exchange Commission on June 25, 2026, disclosing a material event.
8k filedNASDAQ:MLTX
MoonLake Immunotherapeutics (MLTX) Reports Material Event to SEC
Filing Details MoonLake Immunotherapeutics (NASDAQ:MLTX) filed a Form 8-K with the Securities and Exchange Commission on June 25, 2026, disclosing a material event. Market Context…
Market Context
MoonLake Immunotherapeutics's stock currently trades at $19.99 with a market capitalization of $895.6M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for MoonLake Immunotherapeutics's stock.
All SEC filings for MoonLake Immunotherapeutics are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View MLTX Stock Page
Frequently Asked Questions
Where can I read MLTX's SEC filings?
Browse all filings on our MLTX SEC filings page.
What types of SEC filings does MoonLake Immunotherapeutics file?
Public companies like MoonLake Immunotherapeutics file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.